Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of $57.37 million. The enterprise value is -$76.83 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Adicet Bio has 82.71 million shares outstanding. The number of shares has increased by 74.50% in one year.
| Current Share Class | 82.71M |
| Shares Outstanding | 82.71M |
| Shares Change (YoY) | +74.50% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 43.95% |
| Float | 61.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.10.
| Current Ratio | 9.34 |
| Quick Ratio | 9.15 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -63,314.50 |
Financial Efficiency
Return on equity (ROE) is -55.83% and return on invested capital (ROIC) is -34.67%.
| Return on Equity (ROE) | -55.83% |
| Return on Assets (ROA) | -32.68% |
| Return on Invested Capital (ROIC) | -34.67% |
| Return on Capital Employed (ROCE) | -72.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$771,842 |
| Employee Count | 152 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.45% in the last 52 weeks. The beta is 1.65, so Adicet Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -57.45% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 1.04 |
| Relative Strength Index (RSI) | 52.26 |
| Average Volume (20 Days) | 707,562 |
Short Selling Information
The latest short interest is 2.04 million, so 2.47% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 2.06M |
| Short % of Shares Out | 2.47% |
| Short % of Float | 3.33% |
| Short Ratio (days to cover) | 4.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -126.63M |
| Pretax Income | -139.79M |
| Net Income | -117.32M |
| EBITDA | -120.13M |
| EBIT | -126.63M |
| Earnings Per Share (EPS) | -$1.29 |
Full Income StatementBalance Sheet
The company has $150.44 million in cash and $16.25 million in debt, giving a net cash position of $134.19 million or $1.62 per share.
| Cash & Cash Equivalents | 150.44M |
| Total Debt | 16.25M |
| Net Cash | 134.19M |
| Net Cash Per Share | $1.62 |
| Equity (Book Value) | 161.45M |
| Book Value Per Share | 1.95 |
| Working Capital | 137.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$94.93 million and capital expenditures -$2.37 million, giving a free cash flow of -$97.30 million.
| Operating Cash Flow | -94.93M |
| Capital Expenditures | -2.37M |
| Free Cash Flow | -97.30M |
| FCF Per Share | -$1.18 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |